Document Type

Article

Publication Date

1-1-2021

Publication Title

J Sex Med

Abstract

BACKGROUND: Men who contract coronavirus disease 2019 (COVID-19) appear to have worse clinical outcomes compared with women which raises the possibility of androgen-dependent effects.

AIM: We sought to determine if testosterone replacement therapy (TRT) is associated with worse clinical outcomes.

METHODS: Through a retrospective chart review, we identified 32 men diagnosed with COVID-19 and on TRT. They were propensity score matched to 63 men diagnosed with COVID-19 and not on TRT. Data regarding comorbidities and endpoints such as hospital admission, intensive care unit admission, ventilator utilization, thromboembolic events, and death were extracted. Chi-square and Kruskal-Wallis tests examined differences in categorical and continuous variables, respectively. Logistic regression analysis tested the relationship between TRT status and the study endpoints.

RESULTS: There were no statistically significant differences between the 2 groups, and TRT was not a predictor of any of the endpoints on multivariate analysis.

CONCLUSION: These results suggest that TRT is not associated with a worse clinical outcome in men diagnosed with COVID-19.

Medical Subject Headings

COVID-19; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Retrospective Studies; SARS-CoV-2; Testosterone

PubMed ID

33191186

Volume

18

Issue

1

First Page

215

Last Page

218

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.